Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07039188

Clinical Evaluation of the Femiset Device for Perineal Descent in Women

The University of Antwerp developed a device (Femiset) to alleviate defecation difficulties in women suffering from Descending Perineum Syndrome (DPS). The device allows the patient to apply counterpressure to the site of descent (perineal body) during defecation, thereby correcting the excessive descent of the perineum so that the increase in abdominal pressure during the (attempted) defecation results in the evacuation of the stool from the rectum and anus, rather than a further downward pressure on the already descended perineum.

The aim of the clinical study is to validate the efficacy (improvement in defecation) and safety of Femiset as compared to the standard of care of no support to the perineum through a clinical study on 20 patients. The population to be studied consists of adult women suffering from DPS with symptoms of obstructive defecation. Patients will use the device in their home environment for four weeks. The improvement in defecation as perceived by the patient will be assessed with the Patient Global Impression of Change (PGIC) scale. Secondarily, their ODS symptoms will be assessed prior to the test period and at the end of the test period using the Modified Longo Score for ODS. These scores will be compared to determine if there has been an improvement in ODS symptoms. The safety of the device will be validated based on monitoring the incidence of adverse events during the test period. The study will also explore the usability of the device and how it compares to manual perineal support. The results of the study will determine the product's viability.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Woman at birth
  • Adult (aged 18+)
  • ODS complaints
  • MRI has been performed within the past three years and a perineal descent of >4cm on MRI (M-Line) is present
  • Functional pelvic floor (no dyssynergia)

Exclusion criteria

  • Scoring less than 7/24 on the modified Longo Score for ODS
  • Need for vaginal splinting
  • Severe perineal malformations
  • Recent perineal surgery (<6 weeks)
  • Recent vaginal delivery (<6 weeks)
  • Pregnant or actively trying to conceive
  • Known allergy to the material of the investigational device
  • Inability to follow instructions or handle the device
  • Not able to understand the language of the questionnaires (NL/English)
  • Incapable of giving informed consent

Treatment and study plan

Use device in home environment

Device

Patients will use the device in their home environment for four weeks.

Primary outcomes

  1. Efficacy - improvement in defecation

    Time frame: 4 weeks

    PGIC Scale

  2. Safety - incidence of adverse events

    Time frame: 4 weeks

    Absence of any adverse events classified with a device-related causality level higher than "not related", as per MDCG 2020-10/1, and assessed by the PI as severe.

Secondary outcomes

  1. Efficacy - improvement in ODS symptoms

    Time frame: 4 weeks

    Modified Longo Score for ODS

Study contacts

Contact information is provided by the study sponsor or research team.

Sien Heirbaut, MSc

CONTACT

[email protected]

+32 499212232

Sponsors and collaborators

Lead sponsor

University Hospital, Antwerp

Other

Registry information

Official study title

Clinical Evaluation of the Femiset Device for Perineal Descent in Women - Impact on Stool Evacuation

Acronym: FEMISET

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jun 26, 2025
Registry last updated
Jun 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.